Lv4
448 积分 2024-03-15 加入
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts
22小时前
待确认
A Real World Perspective of PARP Inhibitor Use in Gynecological Cancer Patients
6天前
已完结
Comparative safety and tolerability of approved PARP inhibitors in cancer: A systematic review and network meta-analysis
8天前
已完结
Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database
15天前
已完结
Neurological and Psychiatric Adverse Events Associated with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer Patients: Insights from a Pharmacovigilance Study via the FDA Adverse Event Reporting System
29天前
已完结
Cardiovascular adverse events associated with PARP inhibitors for ovarian cancer: a real world study (RWS) with Bayesian disproportional analysis based on the FDA adverse event reporting system (FAERS)
1个月前
已完结
北京地区基层医疗机构药物治疗管理服务门诊工作实施专家共识（2023）
2个月前
已关闭
Senescent cancer-associated fibroblasts drive early-stage lymph node metastasis in pancreatic cancer through lactate-mediated metabolic-epigenetic rewiring
4个月前
已关闭
Senescent cancer-associated fibroblasts drive early-stage lymph node metastasis in pancreatic cancer through lactate-mediated metabolic-epigenetic rewiring
4个月前
已完结
From geroscience to precision geromedicine: Understanding and managing aging
4个月前
已完结
皖公网安备34019202002308
